4//SEC Filing
Garren Hideki 4
Accession 0000905148-23-000919
CIK 0001559053other
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 7:33 PM ET
Size
9.2 KB
Accession
0000905148-23-000919
Insider Transaction Report
Form 4
Garren Hideki
Chief Medical Officer
Transactions
- Exercise/Conversion
Ordinary Shares, par value $0.01 per share
2023-09-13$24.90/sh+2,000$49,800→ 2,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-09-13−2,000→ 192,000 totalExercise: $24.90Exp: 2031-04-05→ Ordinary Shares (2,000 underlying) - Sale
Ordinary Shares, par value $0.01 per share
2023-09-13$55.48/sh−2,000$110,952→ 0 total
Footnotes (3)
- [F1]The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2023.
- [F2]This transaction was executed in multiple trades in prices ranging from $54.995 to $55.96, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in footnote 2 of this Form 4.
- [F3]The shares subject to the option vested and became exercisable as to 25% of the total number of shares subject to the option on April 5, 2022, and vest and become exercisable with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.
Documents
Issuer
PROTHENA CORP PUBLIC LTD CO
CIK 0001559053
Entity typeother
Related Parties
1- filerCIK 0001854126
Filing Metadata
- Form type
- 4
- Filed
- Sep 12, 8:00 PM ET
- Accepted
- Sep 13, 7:33 PM ET
- Size
- 9.2 KB